Samrat Pharmachem Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 865.07 million compared to INR 472.37 million a year ago. Revenue was INR 865.32 million compared to INR 473.92 million a year ago.

Net income was INR 93.67 million compared to INR 9.54 million a year ago. Basic earnings per share from continuing operations was INR 30.32 compared to INR 3.09 a year ago. Diluted earnings per share from continuing operations was INR 30.32 compared to INR 3.09 a year ago.